Clinical Trial Results:
Multicentre, double blind, placebo-controlled, randomised clinical study to assess the efficacy and safety of Doxium® 500 three times daily in patients suffering from chronic venous insufficiency (CVI) CEAP Class C3 or C4.
Summary
|
|
EudraCT number |
2009-013391-44 |
Trial protocol |
DE PT PL IT |
Global completion date |
18 May 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
11 Dec 2016
|
First version publication date |
11 Dec 2016
|
Other versions |
|
Summary report(s) |
EDX09/01 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.